1202 related articles for article (PubMed ID: 33010357)
1. β-Blocker Use and Risk of Mortality in Heart Failure Patients Initiating Maintenance Dialysis.
Zhou H; Sim JJ; Shi J; Shaw SF; Lee MS; Neyer JR; Kovesdy CP; Kalantar-Zadeh K; Jacobsen SJ
Am J Kidney Dis; 2021 May; 77(5):704-712. PubMed ID: 33010357
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Benefits of Carvedilol, Bisoprolol, and Metoprolol Controlled Release/Extended Release in Hemodialysis Patients with Heart Failure: A 10-Year Cohort.
Tang CH; Wang CC; Chen TH; Hong CY; Sue YM
J Am Heart Assoc; 2016 Jan; 5(1):. PubMed ID: 26738790
[TBL] [Abstract][Full Text] [Related]
3. Older adults with heart failure treated with carvedilol, bisoprolol, or metoprolol tartrate: risk of mortality.
Perreault S; de Denus S; White M; White-Guay B; Bouvier M; Dorais M; Dubé MP; Rouleau JL; Tardif JC; Jenna S; Haibe-Kains B; Leduc R; Deblois D
Pharmacoepidemiol Drug Saf; 2017 Jan; 26(1):81-90. PubMed ID: 27859924
[TBL] [Abstract][Full Text] [Related]
4. A Comparative Study of Carvedilol Versus Metoprolol Initiation and 1-Year Mortality Among Individuals Receiving Maintenance Hemodialysis.
Assimon MM; Brookhart MA; Fine JP; Heiss G; Layton JB; Flythe JE
Am J Kidney Dis; 2018 Sep; 72(3):337-348. PubMed ID: 29653770
[TBL] [Abstract][Full Text] [Related]
5. Beta-blocker choice and exchangeability in patients with heart failure and chronic obstructive pulmonary disease: an Italian register-based cohort study.
Sessa M; Mascolo A; Rasmussen DB; Kragholm K; Jensen MT; Sportiello L; Rafaniello C; Tari GM; Pagliaro C; Andersen M; Rossi F; Capuano A
Sci Rep; 2019 Aug; 9(1):11465. PubMed ID: 31391573
[TBL] [Abstract][Full Text] [Related]
6. Comparative effectiveness of beta-adrenergic antagonists (atenolol, metoprolol tartrate, carvedilol) on the risk of rehospitalization in adults with heart failure.
Go AS; Yang J; Gurwitz JH; Hsu J; Lane K; Platt R
Am J Cardiol; 2007 Aug; 100(4):690-6. PubMed ID: 17697830
[TBL] [Abstract][Full Text] [Related]
7. Relationship between heart failure, concurrent chronic obstructive pulmonary disease and beta-blocker use: a Danish nationwide cohort study.
Sessa M; Mascolo A; Mortensen RN; Andersen MP; Rosano GMC; Capuano A; Rossi F; Gislason G; Enghusen-Poulsen H; Torp-Pedersen C
Eur J Heart Fail; 2018 Mar; 20(3):548-556. PubMed ID: 29159953
[TBL] [Abstract][Full Text] [Related]
8. Association of β-Blocker Use With Heart Failure Hospitalizations and Cardiovascular Disease Mortality Among Patients With Heart Failure With a Preserved Ejection Fraction: A Secondary Analysis of the TOPCAT Trial.
Silverman DN; Plante TB; Infeld M; Callas PW; Juraschek SP; Dougherty GB; Meyer M
JAMA Netw Open; 2019 Dec; 2(12):e1916598. PubMed ID: 31800067
[TBL] [Abstract][Full Text] [Related]
9. β-Blockers and 1-Year Postdischarge Mortality for Heart Failure and Reduced Ejection Fraction and Slow Discharge Heart Rate.
Park JJ; Park HA; Cho HJ; Lee HY; Kim KH; Yoo BS; Kang SM; Baek SH; Jeon ES; Kim JJ; Cho MC; Chae SC; Oh BH; Choi DJ
J Am Heart Assoc; 2019 Feb; 8(4):e011121. PubMed ID: 30755071
[TBL] [Abstract][Full Text] [Related]
10. Evaluating the effectiveness of different beta-adrenoceptor blockers in heart failure patients.
Lin TY; Chen CY; Huang YB
Int J Cardiol; 2017 Mar; 230():378-383. PubMed ID: 28041715
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the clinical outcome of different beta-blockers in heart failure patients: a retrospective nationwide cohort study.
Bølling R; Scheller NM; Køber L; Poulsen HE; Gislason GH; Torp-Pedersen C
Eur J Heart Fail; 2014 Jun; 16(6):678-84. PubMed ID: 24706485
[TBL] [Abstract][Full Text] [Related]
12. Association Between β-Blocker Use and Mortality/Morbidity in Patients With Heart Failure With Reduced, Midrange, and Preserved Ejection Fraction and Advanced Chronic Kidney Disease.
Fu EL; Uijl A; Dekker FW; Lund LH; Savarese G; Carrero JJ
Circ Heart Fail; 2020 Nov; 13(11):e007180. PubMed ID: 33070637
[TBL] [Abstract][Full Text] [Related]
13. Carvedilol, Bisoprolol, and Metoprolol Use in Patients With Coexistent Heart Failure and Chronic Obstructive Pulmonary Disease.
Su VY; Chang YS; Hu YW; Hung MH; Ou SM; Lee FY; Chou KT; Yang KY; Perng DW; Chen TJ; Liu CJ
Medicine (Baltimore); 2016 Feb; 95(5):e2427. PubMed ID: 26844454
[TBL] [Abstract][Full Text] [Related]
14. Trends in the Use of Guideline-Directed Therapies Among Dialysis Patients Hospitalized With Systolic Heart Failure: Findings From the American Heart Association Get With The Guidelines-Heart Failure Program.
Pandey A; Golwala H; DeVore AD; Lu D; Madden G; Bhatt DL; Schulte PJ; Heidenreich PA; Yancy CW; Hernandez AF; Fonarow GC
JACC Heart Fail; 2016 Aug; 4(8):649-61. PubMed ID: 27179827
[TBL] [Abstract][Full Text] [Related]
15. β-Blocker dialyzability and mortality in older patients receiving hemodialysis.
Weir MA; Dixon SN; Fleet JL; Roberts MA; Hackam DG; Oliver MJ; Suri RS; Quinn RR; Ozair S; Beyea MM; Kitchlu A; Garg AX
J Am Soc Nephrol; 2015 Apr; 26(4):987-96. PubMed ID: 25359874
[TBL] [Abstract][Full Text] [Related]
16. The evaluation of β-adrenoceptor blocking agents in patients with COPD and congestive heart failure: a nationwide study.
Liao KM; Lin TY; Huang YB; Kuo CC; Chen CY
Int J Chron Obstruct Pulmon Dis; 2017; 12():2573-2581. PubMed ID: 28894360
[TBL] [Abstract][Full Text] [Related]
17. Association of treatment with carvedilol vs metoprolol succinate and mortality in patients with heart failure.
Pasternak B; Svanström H; Melbye M; Hviid A
JAMA Intern Med; 2014 Oct; 174(10):1597-604. PubMed ID: 25173681
[TBL] [Abstract][Full Text] [Related]
18.
Tieu A; Velenosi TJ; Kucey AS; Weir MA; Urquhart BL
Clin J Am Soc Nephrol; 2018 Apr; 13(4):604-611. PubMed ID: 29519953
[TBL] [Abstract][Full Text] [Related]
19. Hypoglycemia-Related Hospitalizations and Mortality Among Patients With Diabetes Transitioning to Dialysis.
Rhee CM; Kovesdy CP; You AS; Sim JJ; Soohoo M; Streja E; Molnar MZ; Amin AN; Abbott K; Nguyen DV; Kalantar-Zadeh K
Am J Kidney Dis; 2018 Nov; 72(5):701-710. PubMed ID: 30037725
[TBL] [Abstract][Full Text] [Related]
20. Heart failure as a cause for hospitalization in chronic dialysis patients.
Trespalacios FC; Taylor AJ; Agodoa LY; Bakris GL; Abbott KC
Am J Kidney Dis; 2003 Jun; 41(6):1267-77. PubMed ID: 12776280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
